{"name":"Teva Branded Pharmaceutical Products R&D, Inc.","slug":"teva-branded-pharmaceutical-products-r-d-inc","ticker":"","exchange":"","domain":"tevapharm.com","description":"","hq":"Tel Aviv","founded":0,"employees":"","ceo":"Richard Francis","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":24,"colorKey":"oncology","drugs":[{"name":"Standard of Care Rescue Medication","genericName":"Standard of Care Rescue Medication","slug":"standard-of-care-rescue-medication","indication":"Other","status":"marketed"},{"name":"Fp/ABS","genericName":"Fp/ABS","slug":"fp-abs","indication":"Unknown","status":"phase_3"},{"name":"Placebo MDPI","genericName":"Placebo MDPI","slug":"placebo-mdpi","indication":"Other","status":"phase_3"},{"name":"TEV-48125 - 3","genericName":"TEV-48125 - 3","slug":"tev-48125-3","indication":"Other","status":"phase_1"},{"name":"ACR16","genericName":"ACR16","slug":"acr16","indication":"Other","status":"phase_3"},{"name":"Albuterol-HFA-BAI","genericName":"Albuterol-HFA-BAI","slug":"albuterol-hfa-bai","indication":"Other","status":"marketed"},{"name":"BDP Nasal Aerosol","genericName":"BDP Nasal Aerosol","slug":"bdp-nasal-aerosol","indication":"Allergic rhinitis","status":"phase_3"},{"name":"Beclomethasone dipropionate HFA Nasal Aerosol","genericName":"Beclomethasone dipropionate HFA Nasal Aerosol","slug":"beclomethasone-dipropionate-hfa-nasal-aerosol","indication":"Allergic rhinitis","status":"phase_2"},{"name":"Bronchodilator","genericName":"Bronchodilator","slug":"bronchodilator","indication":"Other","status":"phase_2"},{"name":"Depo-subQ Provera","genericName":"Depo-subQ Provera","slug":"depo-subq-provera","indication":"Contraception (prevention of pregnancy)","status":"marketed"},{"name":"Experimental Glatiramer Acetate","genericName":"Experimental Glatiramer Acetate","slug":"experimental-glatiramer-acetate","indication":"Other","status":"phase_3"},{"name":"FLOVENT HFA","genericName":"FLOVENT HFA","slug":"flovent-hfa","indication":"Other","status":"marketed"},{"name":"Fluticasone Propionate MDPI","genericName":"Fluticasone Propionate MDPI","slug":"fluticasone-propionate-mdpi","indication":"Other","status":"phase_1"},{"name":"Kariva®","genericName":"Kariva®","slug":"kariva","indication":"Contraception (prevention of pregnancy)","status":"marketed"},{"name":"LBR-101 Low Dose","genericName":"LBR-101 Low Dose","slug":"lbr-101-low-dose","indication":"Other","status":"phase_2"},{"name":"Mircette®","genericName":"Mircette®","slug":"mircette","indication":"Contraception (prevention of pregnancy)","status":"phase_3"},{"name":"Neugranin","genericName":"Neugranin","slug":"neugranin","indication":"Other","status":"phase_3"},{"name":"Placebo BAI","genericName":"Placebo BAI","slug":"placebo-bai","indication":"Clinical trial control comparator (not a therapeutic indication)","status":"phase_3"},{"name":"Placebo Nasal Aerosol","genericName":"Placebo Nasal Aerosol","slug":"placebo-nasal-aerosol","indication":"Other","status":"phase_3"},{"name":"Placebo breath-actuated inhaler","genericName":"Placebo breath-actuated inhaler","slug":"placebo-breath-actuated-inhaler","indication":"Clinical trial control/comparator (not a therapeutic indication)","status":"phase_3"},{"name":"ProAir® HFA","genericName":"ProAir® HFA","slug":"proair-hfa","indication":"Acute relief of bronchospasm in patients with reversible obstructive airway disease","status":"marketed"},{"name":"laquinimod 0.3","genericName":"laquinimod 0.3","slug":"laquinimod-0-3","indication":"Other","status":"phase_2"},{"name":"placebo aerosol by HFA","genericName":"placebo aerosol by HFA","slug":"placebo-aerosol-by-hfa","indication":"Other","status":"phase_3"},{"name":"tbo-filgrastim","genericName":"tbo-filgrastim","slug":"tbo-filgrastim","indication":"Other","status":"discontinued"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":20,"colorKey":"immunology","drugs":[{"name":"Albuterol/salmeterol HFA MDI","genericName":"Albuterol/salmeterol HFA MDI","slug":"albuterol-salmeterol-hfa-mdi","indication":"Asthma maintenance and acute symptom relief","status":"phase_3"},{"name":"Qvar","genericName":"Qvar","slug":"qvar","indication":"Asthma maintenance treatment","status":"marketed"},{"name":"Servent Diskus","genericName":"Servent Diskus","slug":"servent-diskus","indication":"Maintenance treatment of asthma","status":"marketed"},{"name":"Standard of Care Asthma Medication","genericName":"Standard of Care Asthma Medication","slug":"standard-of-care-asthma-medication","indication":"Asthma (maintenance and/or rescue therapy)","status":"marketed"},{"name":"Albuterol HFA-BOI","genericName":"Albuterol HFA-BOI","slug":"albuterol-hfa-boi","indication":"Asthma (acute bronchospasm relief and maintenance)","status":"phase_2"},{"name":"Albuterol MDPI","genericName":"Albuterol MDPI","slug":"albuterol-mdpi","indication":"Acute bronchospasm and reversible airway obstruction in asthma","status":"phase_3"},{"name":"Albuterol eMDPI DS","genericName":"Albuterol eMDPI DS","slug":"albuterol-emdpi-ds","indication":"Acute bronchospasm and reversible airway obstruction in asthma","status":"marketed"},{"name":"Albuterol sulfate (ABS)","genericName":"Albuterol sulfate (ABS)","slug":"albuterol-sulfate-abs","indication":"Asthma (acute bronchospasm relief and maintenance)","status":"phase_3"},{"name":"Albuterol-HFA-MDI","genericName":"Albuterol-HFA-MDI","slug":"albuterol-hfa-mdi","indication":"Acute bronchospasm relief in asthma","status":"marketed"},{"name":"BDP","genericName":"BDP","slug":"bdp","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"BDP HFA","genericName":"BDP HFA","slug":"bdp-hfa","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Beclomethasone Dipropionate 640","genericName":"Beclomethasone Dipropionate 640","slug":"beclomethasone-dipropionate-640","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Beclomethasone dipropionate BAI","genericName":"Beclomethasone dipropionate BAI","slug":"beclomethasone-dipropionate-bai","indication":"Asthma (maintenance and reliever therapy)","status":"phase_3"},{"name":"Beclomethasone dipropionate MDI","genericName":"Beclomethasone dipropionate MDI","slug":"beclomethasone-dipropionate-mdi","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Beclomethasone dipropionate breath-actuated inhaler","genericName":"Beclomethasone dipropionate breath-actuated inhaler","slug":"beclomethasone-dipropionate-breath-actuated-inhaler","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Budesonide/Formoterol SPIROMAX®","genericName":"Budesonide/Formoterol SPIROMAX®","slug":"budesonide-formoterol-spiromax","indication":"Asthma maintenance and reliever therapy","status":"phase_3"},{"name":"Proventil® HFA","genericName":"Proventil® HFA","slug":"proventil-hfa","indication":"Acute bronchospasm relief in asthma","status":"marketed"},{"name":"albuterol aerosol by HFA BOI","genericName":"albuterol aerosol by HFA BOI","slug":"albuterol-aerosol-by-hfa-boi","indication":"Maintenance and relief of bronchospasm in asthma and other chronic lung diseases","status":"phase_3"},{"name":"albuterol aerosol by HFA MDI","genericName":"albuterol aerosol by HFA MDI","slug":"albuterol-aerosol-by-hfa-mdi","indication":"Maintenance and relief of bronchospasm in asthma and in COPD","status":"phase_3"},{"name":"albuterol/salbutamol HFA","genericName":"albuterol/salbutamol HFA","slug":"albuterol-salbutamol-hfa","indication":"Maintenance and relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD)","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"neuroscience","drugs":[{"name":"FS MDPI","genericName":"FS MDPI","slug":"fs-mdpi","indication":"Major depressive disorder","status":"phase_3"},{"name":"Fp MDPI","genericName":"Fp MDPI","slug":"fp-mdpi","indication":"Relapsing forms of multiple sclerosis","status":"phase_3"},{"name":"TEV-56248","genericName":"TEV-56248","slug":"tev-56248","indication":"Migraine prevention","status":"phase_3"},{"name":"ADASUVE®","genericName":"ADASUVE®","slug":"adasuve","indication":"Acute agitation associated with schizophrenia or bipolar disorder","status":"phase_2"},{"name":"Glatiramer Acetate (DB)","genericName":"Glatiramer Acetate (DB)","slug":"glatiramer-acetate-db","indication":"Relapsing-remitting multiple sclerosis (RRMS)","status":"phase_3"},{"name":"Glatiramer Acetate (OL)","genericName":"Glatiramer Acetate (OL)","slug":"glatiramer-acetate-ol","indication":"Relapsing-remitting multiple sclerosis (RRMS)","status":"phase_3"},{"name":"Glatiramer acetate (GA)","genericName":"Glatiramer acetate (GA)","slug":"glatiramer-acetate-ga","indication":"Relapsing-remitting multiple sclerosis (RRMS)","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"DR-102","genericName":"DR-102","slug":"dr-102","indication":"Moderate to severe atopic dermatitis","status":"phase_3"},{"name":"desogestrel/ethinyl estradiol","genericName":"desogestrel/ethinyl estradiol","slug":"desogestrel-ethinyl-estradiol","indication":"Contraception (prevention of pregnancy)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"respiratory","drugs":[{"name":"ABS","genericName":"ABS","slug":"abs","indication":"Prevention of cardiovascular thrombotic events in patients at risk of such events, reduction of the risk of recurrent ischemic strokes in patients with a history of ischemic stroke or transient ischemic attack","status":"marketed"},{"name":"TV-46000","genericName":"TV-46000","slug":"tv-46000","indication":"Atrial fibrillation for stroke prevention","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"rare","drugs":[{"name":"Fludeoxyglucose F 18 (FDG)","genericName":"Fludeoxyglucose F 18 (FDG)","slug":"fludeoxyglucose-f-18-fdg","indication":"Detection and staging of cancer (lung, breast, colorectal, lymphoma, melanoma)","status":"marketed"},{"name":"Oral Corticosteroid (OCS)","genericName":"Oral Corticosteroid (OCS)","slug":"oral-corticosteroid-ocs","indication":"Inflammatory and autoimmune disorders (e.g., rheumatoid arthritis, lupus, vasculitis)","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Prednisone capsules","genericName":"Prednisone capsules","slug":"prednisone-capsules","indication":"Rheumatoid arthritis","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"metabolic","drugs":[{"name":"Hydrocodone ER","genericName":"Hydrocodone ER","slug":"hydrocodone-er","indication":"Moderate to severe chronic pain requiring continuous opioid therapy","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"ophthalmology","drugs":[{"name":"TV-46763","genericName":"TV-46763","slug":"tv-46763","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Standard of Care Rescue Medication","genericName":"Standard of Care Rescue Medication","slug":"standard-of-care-rescue-medication","phase":"marketed","mechanism":"Standard of Care Rescue Medication refers to an established, approved therapeutic agent used as a backup treatment when primary therapies fail or are contraindicated.","indications":[],"catalyst":""},{"name":"Albuterol/salmeterol HFA MDI","genericName":"Albuterol/salmeterol HFA MDI","slug":"albuterol-salmeterol-hfa-mdi","phase":"phase_3","mechanism":"Albuterol and salmeterol are beta-2 adrenergic agonists that relax airway smooth muscle to improve breathing, with albuterol providing rapid relief and salmeterol offering sustained bronchodilation.","indications":["Asthma maintenance and acute symptom relief","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"DR-102","genericName":"DR-102","slug":"dr-102","phase":"phase_3","mechanism":"DR-102 is a small molecule that inhibits the activity of a specific enzyme.","indications":["Moderate to severe atopic dermatitis"],"catalyst":""},{"name":"FS MDPI","genericName":"FS MDPI","slug":"fs-mdpi","phase":"phase_3","mechanism":"FS MDPI is a monoamine oxidase inhibitor that increases levels of dopamine, norepinephrine, and serotonin in the central nervous system.","indications":["Major depressive disorder"],"catalyst":""},{"name":"Fp MDPI","genericName":"Fp MDPI","slug":"fp-mdpi","phase":"phase_3","mechanism":"Fp MDPI is a small molecule that targets the sphingosine-1-phosphate receptor 1 (S1PR1) to modulate immune cell trafficking.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Fp/ABS","genericName":"Fp/ABS","slug":"fp-abs","phase":"phase_3","mechanism":"Fp/ABS is a medication that works by inhibiting the action of a specific enzyme.","indications":["Unknown"],"catalyst":""},{"name":"Placebo MDPI","genericName":"Placebo MDPI","slug":"placebo-mdpi","phase":"phase_3","mechanism":"Placebo MDPI is an inert control formulation with no active pharmacological mechanism.","indications":[],"catalyst":""},{"name":"Prednisone capsules","genericName":"Prednisone capsules","slug":"prednisone-capsules","phase":"phase_3","mechanism":"Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in cells.","indications":["Rheumatoid arthritis","Systemic lupus erythematosus","Polymyalgia rheumatica","Giant cell arteritis","Asthma"],"catalyst":""},{"name":"Qvar","genericName":"Qvar","slug":"qvar","phase":"marketed","mechanism":"Qvar is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","indications":["Asthma maintenance treatment","Asthma prophylaxis"],"catalyst":""},{"name":"Servent Diskus","genericName":"Servent Diskus","slug":"servent-diskus","phase":"marketed","mechanism":"Salmeterol is a long-acting beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing bronchodilation and improved airflow.","indications":["Maintenance treatment of asthma","Maintenance treatment of chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Standard of Care Asthma Medication","genericName":"Standard of Care Asthma Medication","slug":"standard-of-care-asthma-medication","phase":"marketed","mechanism":"Standard of care asthma medications typically work by reducing airway inflammation and/or dilating airways to improve breathing.","indications":["Asthma (maintenance and/or rescue therapy)"],"catalyst":""},{"name":"TEV-48125 - 3","genericName":"TEV-48125 - 3","slug":"tev-48125-3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TEV-56248","genericName":"TEV-56248","slug":"tev-56248","phase":"phase_3","mechanism":"TEV-56248 is a small molecule drug that acts as a selective inhibitor of the sodium-activated potassium channel, KCNN4.","indications":["Migraine prevention"],"catalyst":""},{"name":"ABS","genericName":"ABS","slug":"abs","phase":"marketed","mechanism":"Acetylsalicylic acid acts as a non-selective COX inhibitor, reducing inflammation and platelet aggregation.","indications":["Prevention of cardiovascular thrombotic events in patients at risk of such events, reduction of the risk of recurrent ischemic strokes in patients with a history of ischemic stroke or transient ischemic attack","Relief of pain and inflammation in various conditions"],"catalyst":""},{"name":"ACR16","genericName":"ACR16","slug":"acr16","phase":"phase_3","mechanism":"ACR16 is an investigational therapeutic in phase 3 development by Teva, but its specific mechanism of action is not publicly disclosed.","indications":[],"catalyst":""},{"name":"ADASUVE®","genericName":"ADASUVE®","slug":"adasuve","phase":"phase_2","mechanism":"ADASUVE is a loxapine inhalation powder that blocks dopamine receptors in the brain to rapidly reduce agitation.","indications":["Acute agitation associated with schizophrenia or bipolar disorder"],"catalyst":""},{"name":"Albuterol HFA-BOI","genericName":"Albuterol HFA-BOI","slug":"albuterol-hfa-boi","phase":"phase_2","mechanism":"Albuterol is a beta-2 adrenergic agonist that stimulates beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","indications":["Asthma (acute bronchospasm relief and maintenance)","Chronic obstructive pulmonary disease (COPD) (acute bronchospasm relief)"],"catalyst":""},{"name":"Albuterol MDPI","genericName":"Albuterol MDPI","slug":"albuterol-mdpi","phase":"phase_3","mechanism":"Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","indications":["Acute bronchospasm and reversible airway obstruction in asthma","Chronic obstructive pulmonary disease (COPD) with reversible airway obstruction"],"catalyst":""},{"name":"Albuterol eMDPI DS","genericName":"Albuterol eMDPI DS","slug":"albuterol-emdpi-ds","phase":"marketed","mechanism":"Albuterol is a beta-2 adrenergic agonist that stimulates beta-2 receptors on airway smooth muscle to cause bronchodilation and improve airflow.","indications":["Acute bronchospasm and reversible airway obstruction in asthma","Chronic obstructive pulmonary disease (COPD) with reversible airway obstruction"],"catalyst":""},{"name":"Albuterol sulfate (ABS)","genericName":"Albuterol sulfate (ABS)","slug":"albuterol-sulfate-abs","phase":"phase_3","mechanism":"Albuterol sulfate is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","indications":["Asthma (acute bronchospasm relief and maintenance)","Chronic obstructive pulmonary disease (COPD) (acute bronchospasm relief and maintenance)","Exercise-induced bronchoconstriction prevention"],"catalyst":""},{"name":"Albuterol-HFA-BAI","genericName":"Albuterol-HFA-BAI","slug":"albuterol-hfa-bai","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Albuterol-HFA-MDI","genericName":"Albuterol-HFA-MDI","slug":"albuterol-hfa-mdi","phase":"marketed","mechanism":"Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation.","indications":["Acute bronchospasm relief in asthma","Chronic obstructive pulmonary disease (COPD) maintenance and acute symptom relief","Exercise-induced bronchoconstriction prevention"],"catalyst":""},{"name":"BDP","genericName":"BDP","slug":"bdp","phase":"phase_3","mechanism":"BDP is a inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"BDP HFA","genericName":"BDP HFA","slug":"bdp-hfa","phase":"phase_3","mechanism":"BDP HFA is a inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in the lungs.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"BDP Nasal Aerosol","genericName":"BDP Nasal Aerosol","slug":"bdp-nasal-aerosol","phase":"phase_3","mechanism":"BDP (beclomethasone dipropionate) is a corticosteroid that reduces inflammation in the nasal airways by suppressing immune responses and decreasing inflammatory mediator release.","indications":["Allergic rhinitis","Non-allergic rhinitis","Nasal inflammation and congestion"],"catalyst":""},{"name":"Beclomethasone Dipropionate 640","genericName":"Beclomethasone Dipropionate 640","slug":"beclomethasone-dipropionate-640","phase":"phase_3","mechanism":"Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in the lungs.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Beclomethasone dipropionate BAI","genericName":"Beclomethasone dipropionate BAI","slug":"beclomethasone-dipropionate-bai","phase":"phase_3","mechanism":"Beclomethasone dipropionate is a corticosteroid that suppresses inflammatory and immune responses by binding to glucocorticoid receptors in target tissues.","indications":["Asthma (maintenance and reliever therapy)","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Beclomethasone dipropionate HFA Nasal Aerosol","genericName":"Beclomethasone dipropionate HFA Nasal Aerosol","slug":"beclomethasone-dipropionate-hfa-nasal-aerosol","phase":"phase_2","mechanism":"Beclomethasone dipropionate is a corticosteroid that binds to glucocorticoid receptors, reducing inflammation and immune responses in the nasal passages.","indications":["Allergic rhinitis","Non-allergic rhinitis"],"catalyst":""},{"name":"Beclomethasone dipropionate MDI","genericName":"Beclomethasone dipropionate MDI","slug":"beclomethasone-dipropionate-mdi","phase":"phase_3","mechanism":"Beclomethasone dipropionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Beclomethasone dipropionate breath-actuated inhaler","genericName":"Beclomethasone dipropionate breath-actuated inhaler","slug":"beclomethasone-dipropionate-breath-actuated-inhaler","phase":"phase_3","mechanism":"Beclomethasone dipropionate is a corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors and suppressing inflammatory mediator release.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Bronchodilator","genericName":"Bronchodilator","slug":"bronchodilator","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Budesonide/Formoterol SPIROMAX®","genericName":"Budesonide/Formoterol SPIROMAX®","slug":"budesonide-formoterol-spiromax","phase":"phase_3","mechanism":"Budesonide/Formoterol combines an inhaled corticosteroid that reduces airway inflammation with a long-acting beta-2 agonist that relaxes airway smooth muscle.","indications":["Asthma maintenance and reliever therapy","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"Depo-subQ Provera","genericName":"Depo-subQ Provera","slug":"depo-subq-provera","phase":"marketed","mechanism":"Depo-subQ Provera is a progestin that suppresses the luteinizing hormone surge, preventing ovulation and providing contraceptive efficacy.","indications":["Contraception (prevention of pregnancy)"],"catalyst":""},{"name":"Experimental Glatiramer Acetate","genericName":"Experimental Glatiramer Acetate","slug":"experimental-glatiramer-acetate","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"FLOVENT HFA","genericName":"FLOVENT HFA","slug":"flovent-hfa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fludeoxyglucose F 18 (FDG)","genericName":"Fludeoxyglucose F 18 (FDG)","slug":"fludeoxyglucose-f-18-fdg","phase":"marketed","mechanism":"Fludeoxyglucose F-18 is a glucose analog labeled with fluorine-18 that accumulates in tissues with high metabolic activity, enabling detection via positron emission tomography (PET) imaging.","indications":["Detection and staging of cancer (lung, breast, colorectal, lymphoma, melanoma)","Evaluation of dementia and neurodegenerative disorders","Assessment of myocardial viability in cardiac disease"],"catalyst":""},{"name":"Fluticasone Propionate MDPI","genericName":"Fluticasone Propionate MDPI","slug":"fluticasone-propionate-mdpi","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Glatiramer Acetate (DB)","genericName":"Glatiramer Acetate (DB)","slug":"glatiramer-acetate-db","phase":"phase_3","mechanism":"Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting the differentiation of T cells toward anti-inflammatory phenotypes, reducing attacks on myelin in the central nervous system.","indications":["Relapsing-remitting multiple sclerosis (RRMS)","Clinically isolated syndrome (CIS) with high risk of developing multiple sclerosis"],"catalyst":""},{"name":"Glatiramer Acetate (OL)","genericName":"Glatiramer Acetate (OL)","slug":"glatiramer-acetate-ol","phase":"phase_3","mechanism":"Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting anti-inflammatory T cell and B cell responses against myelin antigens.","indications":["Relapsing-remitting multiple sclerosis (RRMS)","Clinically isolated syndrome (CIS) with high risk of MS"],"catalyst":""},{"name":"Glatiramer acetate (GA)","genericName":"Glatiramer acetate (GA)","slug":"glatiramer-acetate-ga","phase":"marketed","mechanism":"Glatiramer acetate is a synthetic polypeptide that modulates immune responses by promoting the differentiation of T cells toward anti-inflammatory phenotypes and reducing autoreactive T cell responses in multiple sclerosis.","indications":["Relapsing-remitting multiple sclerosis (RRMS)","Clinically isolated syndrome (CIS) with high risk of developing multiple sclerosis"],"catalyst":""},{"name":"Hydrocodone ER","genericName":"Hydrocodone ER","slug":"hydrocodone-er","phase":"phase_3","mechanism":"Hydrocodone is an opioid agonist that binds to mu-opioid receptors in the central nervous system to reduce pain perception and provide analgesia.","indications":["Moderate to severe chronic pain requiring continuous opioid therapy"],"catalyst":""},{"name":"Kariva®","genericName":"Kariva®","slug":"kariva","phase":"marketed","mechanism":"Kariva is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and desogestrel.","indications":["Contraception (prevention of pregnancy)"],"catalyst":""},{"name":"LBR-101 Low Dose","genericName":"LBR-101 Low Dose","slug":"lbr-101-low-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mircette®","genericName":"Mircette®","slug":"mircette","phase":"phase_3","mechanism":"Mircette is a combined oral contraceptive that prevents pregnancy by suppressing ovulation through progestin and estrogen hormones.","indications":["Contraception (prevention of pregnancy)"],"catalyst":""},{"name":"Neugranin","genericName":"Neugranin","slug":"neugranin","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Oral Corticosteroid (OCS)","genericName":"Oral Corticosteroid (OCS)","slug":"oral-corticosteroid-ocs","phase":"marketed","mechanism":"Oral corticosteroids suppress the immune system and reduce inflammation by binding to glucocorticoid receptors in the cytoplasm and modulating gene transcription.","indications":["Inflammatory and autoimmune disorders (e.g., rheumatoid arthritis, lupus, vasculitis)","Allergic reactions and asthma exacerbations","Adrenal insufficiency","Certain hematologic malignancies and lymphomas","Organ transplant rejection prophylaxis"],"catalyst":""},{"name":"Placebo BAI","genericName":"Placebo BAI","slug":"placebo-bai","phase":"phase_3","mechanism":"Placebo BAI is an inert substance with no active pharmacological mechanism.","indications":["Clinical trial control comparator (not a therapeutic indication)"],"catalyst":""},{"name":"Placebo Nasal Aerosol","genericName":"Placebo Nasal Aerosol","slug":"placebo-nasal-aerosol","phase":"phase_3","mechanism":"A placebo nasal aerosol contains no active pharmaceutical ingredient and produces therapeutic effects through the placebo effect.","indications":[],"catalyst":""},{"name":"Placebo breath-actuated inhaler","genericName":"Placebo breath-actuated inhaler","slug":"placebo-breath-actuated-inhaler","phase":"phase_3","mechanism":"A placebo inhaler device that delivers no active pharmaceutical ingredient, used as a control comparator in clinical trials.","indications":["Clinical trial control/comparator (not a therapeutic indication)"],"catalyst":""},{"name":"ProAir® HFA","genericName":"ProAir® HFA","slug":"proair-hfa","phase":"marketed","mechanism":"ProAir HFA is a short-acting beta-2 adrenergic agonist that relaxes airway smooth muscle to rapidly relieve bronchospasm and improve airflow in the lungs.","indications":["Acute relief of bronchospasm in patients with reversible obstructive airway disease","Prevention of exercise-induced bronchospasm"],"catalyst":""},{"name":"Proventil® HFA","genericName":"Proventil® HFA","slug":"proventil-hfa","phase":"marketed","mechanism":"Proventil HFA is a short-acting beta-2 adrenergic agonist that relaxes airway smooth muscle to rapidly relieve bronchospasm and improve airflow.","indications":["Acute bronchospasm relief in asthma","Prevention of exercise-induced bronchoconstriction","Maintenance treatment of asthma"],"catalyst":""},{"name":"TV-46000","genericName":"TV-46000","slug":"tv-46000","phase":"phase_3","mechanism":"TV-46000 is a small molecule in development for the treatment of atrial fibrillation.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"TV-46763","genericName":"TV-46763","slug":"tv-46763","phase":"phase_3","mechanism":"TV-46763 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"albuterol aerosol by HFA BOI","genericName":"albuterol aerosol by HFA BOI","slug":"albuterol-aerosol-by-hfa-boi","phase":"phase_3","mechanism":"Albuterol works by stimulating the beta-2 receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle.","indications":["Maintenance and relief of bronchospasm in asthma and other chronic lung diseases"],"catalyst":""},{"name":"albuterol aerosol by HFA MDI","genericName":"albuterol aerosol by HFA MDI","slug":"albuterol-aerosol-by-hfa-mdi","phase":"phase_3","mechanism":"Albuterol works by stimulating the beta-2 adrenergic receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle.","indications":["Maintenance and relief of bronchospasm in asthma and in COPD","Prevention of bronchospasm during exercise"],"catalyst":""},{"name":"albuterol/salbutamol HFA","genericName":"albuterol/salbutamol HFA","slug":"albuterol-salbutamol-hfa","phase":"phase_3","mechanism":"Albuterol/salbutamol HFA is a short-acting beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.","indications":["Maintenance and relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD)","Prevention of bronchospasm during exercise"],"catalyst":""},{"name":"desogestrel/ethinyl estradiol","genericName":"desogestrel/ethinyl estradiol","slug":"desogestrel-ethinyl-estradiol","phase":"marketed","mechanism":"Desogestrel/ethinyl estradiol is a combined oral contraceptive that prevents pregnancy by suppressing ovulation through progestin and estrogen activity.","indications":["Contraception (prevention of pregnancy)","Acne vulgaris (in some formulations)"],"catalyst":""},{"name":"laquinimod 0.3","genericName":"laquinimod 0.3","slug":"laquinimod-0-3","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"placebo aerosol by HFA","genericName":"placebo aerosol by HFA","slug":"placebo-aerosol-by-hfa","phase":"phase_3","mechanism":"This drug is a placebo aerosol by HFA, which does not have a pharmacological effect.","indications":[],"catalyst":""},{"name":"tbo-filgrastim","genericName":"tbo-filgrastim","slug":"tbo-filgrastim","phase":"discontinued","mechanism":"12.1 Mechanism of Action Tbo-filgrastim is a human granulocyte colony-stimulating factor (G-CSF) produced by recombinant DNA technology. Tbo-filgrastim binds to G-CSF receptors and stimulates proliferation of neutrophils. G-CSF is known to stimulate differentiation commitment and some end-cell functional activation, which increases neutrophil counts and activity.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQcmJSV0loajV6WUoyZS1iM25iR3FuZHZOVE9ES0Z2MjZLZUVmN3hxaXFVY3l4SzBDZC1URkZmQVVhSFBZV2VYaE9qNTUzeGJHZzZzZFpGdDhvREZrWldzSjRlVWtmNHZ4NG0xZ1dvVVUwc1M0bjhMWmpnU2tmNkl3Rlc0MUNDb0U1RkNxVC0wS041RXQySEFocGhKRHhzNFFDcWRN?oc=5","date":"2026-02-07","type":"regulatory","source":"lupin.com","summary":"Lupin Receives Approval for Generic Albuterol Sulphate MDI - Lupin | Press Release - lupin.com","headline":"Lupin Receives Approval for Generic Albuterol Sulphate MDI - Lupin | Press Release","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNQ21wOVM5MGs2QzBGMHFoNWtNUFZHQ01OaEZURDNveDJpTmU5YjZtbF9YT0FpbGs4ZjlKVDVJbFAzRmVzVG1UeUVUVTJreTdlSThSdDVQTV9uT2p4OE9QMXN1NFJxRlVIWlF4X3N1bWEwSmJyUlVaTlBSZWlRRktaR2N0Z2wwQ3lJNDhselBoMF9FcTBFajFHQXlyT0J0bzJlWW80OGlZTFJLWEQwcFk5cXBB?oc=5","date":"2026-02-03","type":"pipeline","source":"TradingView","summary":"TEVA PHARMACEUTICAL INDUSTRIES LTD SEC 10-K Report - TradingView","headline":"TEVA PHARMACEUTICAL INDUSTRIES LTD SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQT0d6NEh0eFBVeVJOTmRONWhMMVVxOW9YUXg1bkZSWEd3azVVckpmb1hvMHVZMzVkUHBxa2RMN3hHZk85N1Qza3RyUWlLRjFDWmFlZXNLOVRnaGJSclMwLTNTNXRLcXV4SGoxallwM3QzbC1sMWtIbklaQy1yZi1PUVJ4YXVLclV5dFNhWDUwdGIzQXNucVE?oc=5","date":"2025-10-07","type":"patent","source":"Pharma Voice","summary":"Overcoming past mistakes, generics powerhouse Teva embraces an innovative ‘mindset change’ - Pharma Voice","headline":"Overcoming past mistakes, generics powerhouse Teva embraces an innovative ‘mindset change’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQMkFqR3R5Mmw4WWdUTWVvN0xYM3R4YjVta1RrN0hZSnlNci02aHUtM2FVWEY3TXB2bDk2bEU5Sy1FOVZBZ0JScmtLdjZMc2lfMU9WNVIxblVBSkt2ZGFrNjVsdVNoU0RoS1o0MU9wNnh3RU84ZFJYWVFld1NmY3l2UmtRNnhJdFVpbnNneGhlQWwyNnpKa1Fyak1wVmNiTVgzUjNPdFhLZ0xIZF9FclItdmt0cG02UlVGM1pSdWEtZ2NZTUZWMEYySlJSbk82R090X0ZaZWw0dzluYVhkS3kzTXJTZTBySmJHNXFIcWF4QUNrQXY0UW9ROVhwaVVjTDFUUEhFMHAtaldMemhHTC1kOUVKRmZnRWFKaXZoRm1hOA?oc=5","date":"2025-08-14","type":"trial","source":"globenewswire.com","summary":"Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma - globenewswire.com","headline":"Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxORUpUVGtUanJJUGd3Y3QtU1hublk5dnFwZUV5OVI2MG5zdkg0WFJZWEdBM1dVQTVJN2NlUUlCbWI1SE5SQVlaOGhsNXAzeWRQeEhSbjFEai1GVXBCell1eVhpdHJxY0k0ZEVaVW5iUEpzWWtqakVaSm5sYUZWR0pSemMtdVp2dXpXUklqX1NuVEk4UU5Zb0RVV1U0SElqckpU0gFWQVVfeXFMTXdJeTNOckMxWDVZeDlJZ1Q0OEU2M1c4TTZlbHRSek1tR2VhZl84T2Y2MUx6WDhlbEw0akpGMFBIVjdRRURsOEZxQTc4WldEejZUWWhTSWc?oc=5","date":"2025-07-29","type":"pipeline","source":"Law360","summary":"Teva, Amneal End Case Over Listing Inhaler IP In Orange Book - Law360","headline":"Teva, Amneal End Case Over Listing Inhaler IP In Orange Book - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNT3NQeTNoSWJZV2ZqMC12LVJiYnp6bnZDVTEzaERMbkJVeUFxcjdsZzV1cV8xMURQRFJjUWYwTWROaFU5RmQtY3BKNU14T3d6UGhEX1l5Y3ZOdzBhSWZNLU1nR1pndmhGa0NmZ0NmZW1Dd0J4c3pmS1hBZXZfZjBwWHVhQVFDbUNn?oc=5","date":"2024-12-24","type":"patent","source":"JD Supra","summary":"Federal Circuit Decides Case Involving Orange Book Listing of Device Patents - JD Supra","headline":"Federal Circuit Decides Case Involving Orange Book Listing of Device Patents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOYlFKNUpJMDJpUGpFN2pySFg1el9jVGJXZVFiTzBXX0tVV2hHcTZkNS1nT0pIQXlSVEFmTi1WdkRMSFByUmJkdm9WN1RpaEhNcEtPTTI3bjFnbUtteFJmYWdmWXhpWDNZSGpDVFdDaURNd2RoMTJaM2REVkxMc0dhUjVXWVFidHNsWFlIS3R3amEzcmhVdmQxZUdLWjl3QTJpUWJvbDktVEp3WG02QUtHVzVnbTlQcVYtUmc?oc=5","date":"2024-12-20","type":"regulatory","source":"reuters.com","summary":"Teva loses US appeal to keep inhaler patents on FDA protected drug list - reuters.com","headline":"Teva loses US appeal to keep inhaler patents on FDA protected drug list","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPYlpyTUV5c2hud2pTRGIzMGNzTEJ2U3dTYWoxSFI5R3hQajVzdTRKcTUwc1hJdnY2WHdaNlpwOWs1MHpqQ19Pcl9PU2o0dXBRbGgwTXNmbTVveGpJUW5NOWRKQk1kaGpibWFjbElYdDBpTDgxUVl1WUFLdS1vRlhaU1NHdUNhcmxUQTB5eUxzSTY5bW9vMzA5bUVacVR1VjY1?oc=5","date":"2024-08-06","type":"pipeline","source":"White & Case LLP","summary":"Three Drug Pricing Litigation Issues to Watch in the Second Half of 2024 - White & Case LLP","headline":"Three Drug Pricing Litigation Issues to Watch in the Second Half of 2024 - White & Case LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOdFRTT3NmdkNOSGN0NWhCa0VBRlp1M0xOYWZFMjE0OE5yZjNmWU5CVGVQalJ1VnF3VlhiUl9aU0xqZHY3V3B4aWhxbzVQR0NxWDVmQl9PNGpVa2JzQ21IQmV6WGc2b1h4TWlzVW8ydEdMaEI3OUI2ekxRUlIzMHpuM0U1R0lGcUMtMnRGdEVBYlE1M21ScTBiVXpVUlZMY0NvXzJZOWFGT29aUWhOQnpvdmZrQ0xjRC1OclEzbU1lTEZtYVVXMExWUWxGc1p6bnVVWGUzd3l6b01jbVhaRlpLMGFabmRGa00?oc=5","date":"2024-07-31","type":"pipeline","source":"WilmerHale","summary":"The Interplay: Key Decisions at the Intersection of Antitrust and Life Sciences - July 2024 - WilmerHale","headline":"The Interplay: Key Decisions at the Intersection of Antitrust and Life Sciences - July 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPNTRHQTYxdUh4ajNKa3h1clpDU3NaUDktQnA1aVRVaGxtSkNPaHc3ZnhBRGJxNXV0X2xLRTB5NlNwaUlnc0JzSzZEbnRNXzVXdlBpQTBiclVYNVhwUlMwSDhacnlmTjhPTTVmS0NJZ1pLaDc2a0djOTlVUmg1cmhwczB2ZXpFamRmaDFDWFViZ1pzRDNScVYyS3JabHJaV3VrbUNVbEIxZw?oc=5","date":"2024-06-18","type":"pipeline","source":"Holland & Knight","summary":"Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers - Holland & Knight","headline":"Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers - Holland & Knight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5ISkZydjV4TXc1ZTVXTzFWNlhubWhrQTZvYlRQRW1oRS03aXdjalpCRXdfUmRDNE54dnpNR2RnZEtCenhKRk1nSF83cFJmUFVjendNZ1hrYnpyMnFTQXhfcXBFbDJCNV9OUmM4SVVMM0xpZw?oc=5","date":"2024-05-16","type":"patent","source":"Massachusetts Lawyers Weekly","summary":"Antitrust – Generic drug - Massachusetts Lawyers Weekly","headline":"Antitrust – Generic drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPckJiZXhPLVRnQ2sySWRLLVltdHpoaWF1aVh5VWdWMEFyRjhvaEVQODV4TFQtZzg0cVFDRU9MS3Bhb0VHYm14MzBzcjVPQU1EN0J2MEVDMzRRZV9XdVR4ek1EQlV3N3ZoU3VVandIYlV6SUlmQzQxSnBxMk9Tb3ZBNmZpb2NLMElDbk4wWWFIMklxdWxTcEptY0FlaTRRZDRMdFdZVFhTVE50X09paHEyOVU1LXY2MHFYMml1Z0JGcC02cHI1NC1MZS10blRqTUZVVnNYR0ZwQzRxUQ?oc=5","date":"2024-05-08","type":"pipeline","source":"VitalLaw.com","summary":"ANTITRUST—M.D. Pa.: Antitrust claims over Teva’s asthma inhalers will proceed (May 8, 2024) - VitalLaw.com","headline":"ANTITRUST—M.D. Pa.: Antitrust claims over Teva’s asthma inhalers will proceed (May 8, 2024)","sentiment":"neutral"}],"patents":[],"drugCount":60,"phaseCounts":{"marketed":17,"phase_3":34,"phase_1":2,"phase_2":6,"discontinued":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}